Total Payments
$1,285
2024 Payments
$59.24
Companies
7
Transactions
19
Medicare Patients
3,314
Medicare Billing
$208,892
Payment Breakdown by Category
Travel$755.44 (58.8%)
Food & Beverage$333.64 (26.0%)
Education$195.83 (15.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $755.44 | 4 | 58.8% |
| Food and Beverage | $333.64 | 10 | 26.0% |
| Education | $195.83 | 5 | 15.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $945.93 | 6 | $0 (2017) |
| Astellas Pharma US Inc | $188.33 | 4 | $0 (2021) |
| PFIZER INC. | $62.91 | 4 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $40.22 | 2 | $0 (2024) |
| Novo Nordisk Inc | $16.65 | 1 | $0 (2018) |
| Coloplast Corp | $15.68 | 1 | $0 (2023) |
| Allergan, Inc. | $15.19 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59.24 | 3 | Sumitomo Pharma America, Inc. ($40.22) |
| 2023 | $15.68 | 1 | Coloplast Corp ($15.68) |
| 2022 | $15.19 | 1 | Allergan, Inc. ($15.19) |
| 2021 | $99.95 | 1 | Astellas Pharma US Inc ($99.95) |
| 2019 | $110.08 | 5 | Astellas Pharma US Inc ($66.19) |
| 2018 | $16.65 | 1 | Novo Nordisk Inc ($16.65) |
| 2017 | $968.12 | 7 | BOSTON SCIENTIFIC CORPORATION ($945.93) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/21/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: ONCOLOGY | ||||||
| 01/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: UROLOGY | ||||||
| 01/23/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: HORMONE THERAPY | ||||||
| 06/06/2023 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Continence Care | ||||||
| 06/30/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/30/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.95 | General |
| 11/13/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $51.99 | General |
| 10/16/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 04/02/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 01/23/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 01/17/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: UROLOGY | ||||||
| 09/13/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Diabetes | ||||||
| 09/28/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Urology | ||||||
| 02/10/2017 | BOSTON SCIENTIFIC CORPORATION | GENERAL - BPH (Device) | Food and Beverage | In-kind items and services | $160.56 | General |
| Category: BPH | ||||||
| 02/10/2017 | BOSTON SCIENTIFIC CORPORATION | GENERAL - BPH (Device) | Travel and Lodging | In-kind items and services | $64.77 | General |
| Category: BPH | ||||||
| 02/10/2017 | BOSTON SCIENTIFIC CORPORATION | GENERAL - BPH (Device) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: BPH | ||||||
| 02/09/2017 | BOSTON SCIENTIFIC CORPORATION | GENERAL - BPH (Device) | Travel and Lodging | In-kind items and services | $137.66 | General |
| Category: BPH | ||||||
| 02/08/2017 | BOSTON SCIENTIFIC CORPORATION | GENERAL - BPH (Device) | Travel and Lodging | In-kind items and services | $271.88 | General |
| Category: BPH | ||||||
| 02/07/2017 | BOSTON SCIENTIFIC CORPORATION | GENERAL - BPH (Device) | Travel and Lodging | In-kind items and services | $281.13 | General |
| Category: BPH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 507 | 606 | $104,308 | $33,011 |
| 2022 | 10 | 654 | 789 | $124,833 | $39,956 |
| 2021 | 12 | 998 | 1,251 | $165,520 | $60,101 |
| 2020 | 14 | 1,155 | 1,528 | $222,732 | $75,824 |
Total Patients
3,314
Total Services
4,174
Medicare Billing
$208,892
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 85 | $11,815 | $5,288 | 44.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 61 | $12,078 | $5,180 | 42.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 61 | 73 | $22,434 | $3,952 | 17.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 81 | 105 | $8,925 | $3,335 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 50 | 64 | $8,174 | $2,954 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 33 | 44 | $6,246 | $2,920 | 46.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $6,400 | $2,842 | 44.4% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 11 | 16 | $11,888 | $1,811 | 15.2% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 14 | 14 | $5,151 | $1,374 | 26.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $4,174 | $1,327 | 31.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 44 | 45 | $3,008 | $1,035 | 34.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,210 | $764.10 | 34.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 15 | 15 | $750.00 | $117.00 | 15.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 31 | 33 | $1,056 | $112.53 | 10.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 91 | 119 | $15,623 | $7,325 | 46.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 151 | 194 | $16,060 | $6,460 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 68 | $13,068 | $6,412 | 49.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 69 | 87 | $29,091 | $4,518 | 15.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 36 | 36 | $9,172 | $3,916 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 51 | 59 | $7,542 | $2,568 | 34.0% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 15 | 24 | $17,832 | $2,486 | 13.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 24 | 26 | $3,101 | $1,939 | 62.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $3,570 | $1,646 | 46.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 33 | 33 | $4,290 | $1,452 | 33.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 30 | 37 | $2,363 | $796.18 | 33.7% |
About Dr. John Karod, M.D
Dr. John Karod, M.D is a Urology healthcare provider based in Caribou, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578661542.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Karod, M.D has received a total of $1,285 in payments from pharmaceutical and medical device companies, with $59.24 received in 2024. These payments were reported across 19 transactions from 7 companies. The most common payment nature is "Travel and Lodging" ($755.44).
As a Medicare-enrolled provider, Karod has provided services to 3,314 Medicare beneficiaries, totaling 4,174 services with total Medicare billing of $208,892. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Caribou, ME
- Active Since 09/21/2006
- Last Updated 07/21/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1578661542
Products in Payments
- GENERAL - BPH (Device) $945.93
- XTANDI (Drug) $62.91
- Myrbetriq (Drug) $22.19
- GEMTESA (Drug) $20.65
- ORGOVYX (Drug) $19.57
- Tresiba (Drug) $16.65
- SpeediCath (Device) $15.68
- BOTOX (Biological) $15.19
- MYRBETRIQ (Drug) $14.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.